Reference number : 236-2018-2019-Q3-00037, amendment number : , agreement type : G, recipient legal name : Velenosi, Thomas J, recipient country : US, recipient province : nan, recipient city : Bethesda, recipient postal code : nan, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 150000.0, agreement start date : 2018-10-01, agreement end date : 2021-09-30, description english : Metabolic signatures of triple negative breast cancer sensitivity and resistance to cyclophosphamide and doxorubicin in patient derived tumor xenografts, description french : Metabolic signatures of triple negative breast cancer sensitivity and resistance to cyclophosphamide and doxorubicin in patient derived tumor xenografts, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada